MURPHY ANDREW J bought REGN
October 13, 2026 · Form 4 insider transaction
MURPHY ANDREW J bought 17,000 shares of Regeneron Pharmaceuticals, Inc. at $381.92 per share, a transaction worth $6.49M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,000
Price
$381.92
Total value
$6.49M
InsiderMURPHY ANDREW J
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 13, 2026
Filing dateOctober 15, 2026
Shares owned after64,833
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 7, 2026.